SEC Form D filing

ARTELO BIOSCIENCES, INC., 2026-02-06

An SEC Form D private-offering notice from Solana Beach, CA, a $50,500,000 filer-stated offering target in Biotech. Filed 2026-02-06. The source filing is one click away. For companies that filed this week, open the live feed.

What this filing says

ARTELO BIOSCIENCES, INC. site↗ Verified via SEC Form D

Clinical stage pharmaceutical company developing therapeutics that modulate lipid signaling pathways, including the endocannabinoid system, for conditions such as cancer related anorexia, anxiety, and pain.

Filed 2026-02-06Filed to raise $50,500,000First money in 2026-01-30Raised so far $500,000HQ (as filed) Solana Beach, CASector Biotech web-verified against the company’s own siteStage (inferred) GrowthCall status Call-ready
Source linked the Form D on EDGAR↗Website verified artelobio.com↗Named in the filing 8 executives & directors

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.

Other Form D filings from the same week

each with its own page and its own EDGAR source